中证科创创业创新药、医疗器械两条新指数7日发布

Core Viewpoint - The announcement by China Securities Index Co., Ltd. regarding the launch of the CSI Innovation Drug Index and the CSI Medical Device Index on November 7 aims to provide a broader range of investment options in the innovative pharmaceutical and medical device sectors [1] Group 1: CSI Innovation Drug Index - The CSI Innovation Drug Index will select listed companies from the Sci-Tech Innovation Board and the ChiNext that are involved in innovative drug research and development, as well as services for pharmaceutical companies [1] - This index is designed to reflect the overall performance of listed companies in the innovative drug sector on the Sci-Tech Innovation Board and ChiNext [1] Group 2: CSI Medical Device Index - The CSI Medical Device Index will select listed companies from the Sci-Tech Innovation Board and the ChiNext that provide medical devices, consumables, and in vitro diagnostic products and services [1] - This index aims to represent the overall performance of listed companies in the medical device sector on the Sci-Tech Innovation Board and ChiNext [1]